MX2018015725A - Método para facilitar la maduración del sistema inmunitario de mamíferos. - Google Patents
Método para facilitar la maduración del sistema inmunitario de mamíferos.Info
- Publication number
- MX2018015725A MX2018015725A MX2018015725A MX2018015725A MX2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A
- Authority
- MX
- Mexico
- Prior art keywords
- immune system
- mammalian immune
- growth
- compositions
- milk oligosaccharides
- Prior art date
Links
- 210000000987 immune system Anatomy 0.000 title 1
- 230000035800 maturation Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001542 oligosaccharide Polymers 0.000 abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000474 nursing effect Effects 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Husbandry (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Pediatric Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Las invenciones descritas en la presente hacen referencia, en líneas generales, al uso de composiciones para aumentar la producción de acetato y lactato, y simultáneamente reducir el pH y los niveles de bacterias patogénicas y la inflamación intestinal de un mamífero bebé lactante que incluye seres humanos. En general, estas composiciones comprenden una o más cepas bacterianas seleccionadas por su crecimiento en oligosacáridos de la leche de mamíferos, una fuente de oligosacáridos de leche de mamíferos y, opcionalmente, componentes nutritivos necesarios para el crecimiento del mamífero bebé.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662357820P | 2016-07-01 | 2016-07-01 | |
US201662397788P | 2016-09-21 | 2016-09-21 | |
PCT/US2017/040530 WO2018006080A1 (en) | 2016-07-01 | 2017-06-30 | Method for facilitating maturation of the mammalian immune system |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018015725A true MX2018015725A (es) | 2019-09-09 |
Family
ID=60785488
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018015725A MX2018015725A (es) | 2016-07-01 | 2017-06-30 | Método para facilitar la maduración del sistema inmunitario de mamíferos. |
MX2022009575A MX2022009575A (es) | 2016-07-01 | 2018-12-14 | Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022009575A MX2022009575A (es) | 2016-07-01 | 2018-12-14 | Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero. |
Country Status (9)
Country | Link |
---|---|
US (2) | US11318175B2 (es) |
EP (1) | EP3478093A4 (es) |
CN (2) | CN117385064A (es) |
AU (2) | AU2017290900A1 (es) |
BR (1) | BR112018076927A2 (es) |
CA (1) | CA3029631A1 (es) |
MX (2) | MX2018015725A (es) |
SG (1) | SG11201811227QA (es) |
WO (1) | WO2018006080A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY180910A (en) | 2010-12-31 | 2020-12-11 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
SG10202110501RA (en) | 2010-12-31 | 2021-11-29 | Abbott Lab | Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
WO2018041803A1 (en) * | 2016-08-31 | 2018-03-08 | Prismagen Gmbh | Use of human milk oligosaccharides in calves fattening |
US11524019B2 (en) | 2017-08-21 | 2022-12-13 | Glycom A/S | Synthetic composition for reducing allergy symptoms |
CN111587376A (zh) * | 2017-09-13 | 2020-08-25 | 进化生物系统股份有限公司 | 哺乳动物婴儿的代谢组学修正 |
EP3735130A4 (en) * | 2018-01-03 | 2022-02-16 | Evolve Biosystems, Inc. | METHOD FOR DETERMINING DYSBIosis IN THE INTESTINAL MICROBIOME |
WO2019143871A1 (en) * | 2018-01-17 | 2019-07-25 | Evolve Biosystems, Inc. | Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains |
KR20210016557A (ko) | 2018-05-31 | 2021-02-16 | 글리콤 에이/에스 | 자가면역 질환 치료를 위한 hmo 혼합물 |
GB201900744D0 (en) | 2019-01-18 | 2019-03-06 | Mars Inc | Monitoring tools and diagnostic methods |
GB201900745D0 (en) | 2019-01-18 | 2019-03-06 | Mars Inc | Monitoring tools and diagnostic methods |
GB201900750D0 (en) | 2019-01-18 | 2019-03-06 | Mars Inc | Monitoring tools and diagnostic methods |
GB201900754D0 (en) | 2019-01-18 | 2019-03-06 | Mars Inc | Monitoring tools and diagnostic methods |
GB201914385D0 (en) | 2019-10-04 | 2019-11-20 | Mars Inc | Microbiome Interventions |
CN112870232A (zh) * | 2019-11-29 | 2021-06-01 | 内蒙古伊利实业集团股份有限公司 | 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用 |
CA3179561A1 (en) * | 2020-04-08 | 2021-10-14 | Megmilk Snow Brand Co., Ltd. | Composition for improving gut microbiota |
BG67567B1 (bg) * | 2020-05-27 | 2023-09-15 | Гама Консулт-Калинкин, Прокопов И С-Ие Сд | Метод за количествена оценка за бързо прогнозиране и контрол на дисбиози при кърмачета на възраст от един месец до една година |
JP2024514745A (ja) * | 2021-02-22 | 2024-04-03 | テイト アンド ライル ソリューションズ ユー・エス・エー エル・エル・シー | ラクトバチルス・ムコサエと可溶性食物繊維との組み合わせを用いた方法および組成物 |
EP4094590A1 (en) * | 2021-05-27 | 2022-11-30 | Tate & Lyle Solutions USA LLC | Methods and compositions using combinations of lactobacillus mucosae and soluble dietary fiber |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
EP1920782A1 (en) * | 2006-11-10 | 2008-05-14 | Glycotope Gmbh | Carboyhdrate specific cellular immunity inducing microorganisms and fractions thereof |
CA2760999A1 (en) * | 2009-03-13 | 2010-09-16 | Mariana Barboza | Prebiotic oligosaccharides |
US20110066700A1 (en) * | 2009-09-15 | 2011-03-17 | Jackson Chao | Behavior monitoring system |
CN103402376A (zh) * | 2010-12-31 | 2013-11-20 | 雅培制药有限公司 | 促进有益细菌生长的中性人乳寡糖 |
SG10202110501RA (en) * | 2010-12-31 | 2021-11-29 | Abbott Lab | Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides |
WO2012092155A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
MX2014012362A (es) | 2012-04-13 | 2015-05-07 | Trustees Boston College | Composición prebiótica y métodos de uso. |
WO2014121304A1 (en) | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
WO2014201037A2 (en) | 2013-06-10 | 2014-12-18 | New York University | Methods for manipulating immune responses by altering microbiota |
US9956282B2 (en) * | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
CN114376234A (zh) * | 2014-10-24 | 2022-04-22 | 进化生物系统股份有限公司 | 活化的双歧杆菌及其应用方法 |
KR102606971B1 (ko) | 2014-10-29 | 2023-11-30 | 바이오가이아 에이비 | 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도 |
EP3229595B1 (en) * | 2014-12-12 | 2021-02-03 | The Regents of the University of California | Reduction of milk glycans and their degradation products in the neonate gut |
WO2016105513A1 (en) * | 2014-12-23 | 2016-06-30 | Evolve Biosystems Inc. | Method for the noninvasive detection of activated bifidobacteria |
WO2016141454A1 (en) * | 2015-03-12 | 2016-09-15 | The University Of British Columbia | Bacterial compositions and methods of use thereof |
US20190216861A1 (en) * | 2015-09-22 | 2019-07-18 | Mayo Foundation For Medical Education And Research | Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection |
CN105166914A (zh) * | 2015-10-27 | 2015-12-23 | 江西美庐乳业集团有限公司 | 一种能调节肠道微生态环境,提升宝宝抗病能力、改善腹泻的营养包 |
WO2017084673A1 (en) | 2015-11-17 | 2017-05-26 | Glycom A/S | Synthetic Composition for Treating Antibiotic Associated Complications |
-
2017
- 2017-06-30 AU AU2017290900A patent/AU2017290900A1/en not_active Abandoned
- 2017-06-30 SG SG11201811227QA patent/SG11201811227QA/en unknown
- 2017-06-30 CN CN202311231736.5A patent/CN117385064A/zh active Pending
- 2017-06-30 EP EP17821434.2A patent/EP3478093A4/en active Pending
- 2017-06-30 US US16/314,580 patent/US11318175B2/en active Active
- 2017-06-30 CN CN201780044154.2A patent/CN109475169A/zh active Pending
- 2017-06-30 BR BR112018076927-4A patent/BR112018076927A2/pt not_active Application Discontinuation
- 2017-06-30 WO PCT/US2017/040530 patent/WO2018006080A1/en unknown
- 2017-06-30 CA CA3029631A patent/CA3029631A1/en active Pending
- 2017-06-30 MX MX2018015725A patent/MX2018015725A/es unknown
-
2018
- 2018-12-14 MX MX2022009575A patent/MX2022009575A/es unknown
-
2022
- 2022-03-22 US US17/655,825 patent/US20220313759A1/en active Pending
-
2023
- 2023-07-10 AU AU2023204422A patent/AU2023204422A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2022009575A (es) | 2022-09-09 |
WO2018006080A1 (en) | 2018-01-04 |
EP3478093A1 (en) | 2019-05-08 |
BR112018076927A2 (pt) | 2019-04-02 |
US11318175B2 (en) | 2022-05-03 |
US20220313759A1 (en) | 2022-10-06 |
SG11201811227QA (en) | 2019-01-30 |
CA3029631A1 (en) | 2018-01-04 |
CN109475169A (zh) | 2019-03-15 |
US20190224254A1 (en) | 2019-07-25 |
AU2017290900A1 (en) | 2019-01-17 |
EP3478093A4 (en) | 2020-03-04 |
AU2023204422A1 (en) | 2023-08-03 |
CN117385064A (zh) | 2024-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022009575A (es) | Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero. | |
BR112017027640A2 (pt) | leite fermentado inoculado com ambas bactérias ácido-láticas (lab) e bacilo | |
MX350325B (es) | Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas. | |
NZ729306A (en) | Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use | |
MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
AR101545A1 (es) | Método para producir un producto lácteo fermentado con baja concentración de lactosa | |
PH12017500708A1 (en) | Probiotic and prebiotic compositions | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
NZ706636A (en) | Probiotic and prebiotic compositions | |
EP3554521A4 (en) | ORAL LACTIC ACID BACTERIA COMPOSITION FOR THE REGULATION OF IMMUNE REACTIONS AND RELATED PROCEDURES | |
EP3787668C0 (en) | PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION | |
AR095877A1 (es) | Método para mejorar la calidad de la leche en animales productores de leche | |
BR112018003474A2 (pt) | bactérias lactobacillus fermentum que reduzem a concentração de acetaldeído | |
MX2019015306A (es) | Probioticos y metodos de uso. | |
WO2018232275A3 (en) | ANTIMICROBIAL TREATMENT OF CARCASSES OF ANIMALS AND FOOD PRODUCTS | |
PH12020550651A1 (en) | Gender specific synthetic nutritional compositions comprising lycopene and nutritional systems comprising them | |
MX2019010730A (es) | Suplemento de proteina liquida esterilizada. | |
EA202190286A1 (ru) | Микробиологический способ получения перги | |
MX2017007969A (es) | Bacterias de acido lactico y su uso para el tratamiento de mastitis. | |
SG10201908193PA (en) | Nucleotide composition and application in food thereof | |
MX2021012952A (es) | Vacuna klebsiella y metodos de uso. | |
MX2018014532A (es) | Un metodo para reducir la contaminacion de los huevos. | |
MX2020004347A (es) | Preparacion de productos lacteos fermentados para distribucion ambiental. | |
PH12018500164A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12018500165A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them |